e correction of age-related midface contour deficiencies in patients over the age of 21.Restylane Lyft with Lidocaineis also indicated for injection into the dorsal hand to correct volume loss in patients over the age of 21.Restylane Lyft with Lidocaineis also indicated for injection into the mid-to-deep dermis (subcutaneous and/or supraperiosteal) for augmentation of the chin region to improve the chin profile in patients over the age of 21 with mild-to-moderate chin retrusion.

Restylane Lyft with Lidocainecontains traces of gram-positive bacterial protein and is contraindicated for patients with allergies to such material or for patients with severe allergies that have required in-hospital treatment. This product should not be used by people with bleeding disorders, with hypersensitivity to amide-type local anesthetics, such as lidocaine, or by women who are pregnant or breastfeeding.

The most common side effects reported in the clinical study to support approval
=*=*=*=*=*=
当前为第6/13页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页